2-[(18)F]-Fluoro-3-pyridinecarboxaldehyde ([(18)F]FPCA) is a novel, water-soluble prosthetic group. It's radiochemistry has been developed and fully-automated for application in chemoselective radiolabelling of amino(oxy)-derivatised RI-OR2-TAT peptide, (Aoa-k)-RI-OR2-TAT, using a GE TRACERlab FX-FN. RI-OR2-TAT is a brain-penetrant, retro-inverso peptide that binds to amyloid species associated with Alzheimer's Disease. Radiolabelled (Aoa-k)-RI-OR2-TAT was reproducibly synthesised and the product of the reaction with FPCA has been fully characterised. In-vivo biodistribution of [(18)F]RI-OR2-TAT has been measured in Wistar rats.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034901 | PMC |
| http://dx.doi.org/10.1016/j.apradiso.2016.07.023 | DOI Listing |
Publication Analysis
Top Keywords
prosthetic group
8
development automation
4
automation novel
4
novel [18f]f
4
[18f]f prosthetic
4
group 2-[18f]-fluoro-3-pyridinecarboxaldehyde
4
2-[18f]-fluoro-3-pyridinecarboxaldehyde application
4
application aminooxy-functionalised
4
aminooxy-functionalised aβ
4
aβ peptide
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!